NSRX
Nasus Pharma Ltd.

18
Mkt Cap
$25.06M
Volume
100,136.00
52W High
$9.99
52W Low
$1.98
PE Ratio
-15.08
NSRX Fundamentals
Price
$2.91
Prev Close
$3.18
Open
$3.12
50D MA
$3.51
Beta
1.21
Avg. Volume
443,887.68
EPS (Annual)
-$0.1883
P/B
30.21
Rev/Employee
$0.00
$81.17
Loading...
Loading...

About

Nasus Pharma Ltd. engages in the development of intranasal drugs for emergency medical conditions. It offers Powder-Based Intranasal (PBI) specialized product portfolio, to address acute medical conditions and public health threats. The company was founded by Udi Gilboa and Dalia Megiddo in May 2019 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7

Frequently Asked Questions

What is Market Cap of Nasus Pharma Ltd.?
What is the 52-week high for Nasus Pharma Ltd.?
What is the 52-week low for Nasus Pharma Ltd.?
What is Nasus Pharma Ltd. stock price today?
What was Nasus Pharma Ltd. stock price yesterday?
What is the PE ratio of Nasus Pharma Ltd.?
What is the Price-to-Book ratio of Nasus Pharma Ltd.?
What is the 50-day moving average of Nasus Pharma Ltd.?
How many employees does Nasus Pharma Ltd. have?

Latest NSRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.